טוען...
Treatment of Gastric and Gastroesophageal Cancer Patients with Hemodialysis by CapeOX
Two patients underwent hemodialysis. Case 1 with stage IV gastric cancer was treated with reduced doses of capecitabine (1,000 mg/m(2)/day, days 1 to 14) and oxaliplatin (65 mg/m(2), day 1). Although grade 1 thrombocytopenia occurred in the first cycle, grade 3 thrombocytopenia developed in the seco...
שמור ב:
| הוצא לאור ב: | Intern Med |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Japanese Society of Internal Medicine
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6815905/ https://ncbi.nlm.nih.gov/pubmed/31243213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2718-19 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|